Sign In

Kevin Chow

Biotechnology Executive and Entrepreneur / Operating Partner at Accelerator Life Science Partners

Kevin Chow, a seasoned professional in the biopharmaceutical industry, brings over 20 years of experience in business development and corporate strategy.

Dr. Chow is currently an Operating Partner at Accelerator Life Science Partners and previously served as the Co-founder, President, and CEO of Vitaeris, a biotechnology company acquired by CSL Behring.

He led Vitaeris through a groundbreaking Phase 3 study in kidney transplant rejection, successfully repurposing anti-IL6 mAb clazakizumab for solid organ transplantation under an accelerated FDA approval pathway.

Prior to his role at Vitaeris, Kevin held key positions at Alder Biopharmaceuticals, Gilead Sciences, and Corus Pharma, showcasing his expertise in business development and strategic leadership.

Dr. Chow holds B.Sc., M.Sc., and Ph.D. degrees in Microbiology and Immunology from the University of British Columbia, Vancouver, Canada.

Kevin Chow
Add to my network

Location

Greater Seattle Area